Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2001-12-25
pubmed:abstractText
To analyze the possible correlation between expression of the alphav and beta1 integrin chains and survival in advanced-stage ovarian carcinomas, studying two patient groups with extremely different disease outcome.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4073-9
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:11751504-Adult, pubmed-meshheading:11751504-Aged, pubmed-meshheading:11751504-Aged, 80 and over, pubmed-meshheading:11751504-Antigens, CD, pubmed-meshheading:11751504-Antigens, CD29, pubmed-meshheading:11751504-Disease-Free Survival, pubmed-meshheading:11751504-Female, pubmed-meshheading:11751504-Gene Expression Regulation, Neoplastic, pubmed-meshheading:11751504-Humans, pubmed-meshheading:11751504-Integrin alphaV, pubmed-meshheading:11751504-Middle Aged, pubmed-meshheading:11751504-Neoplasm Staging, pubmed-meshheading:11751504-Ovarian Neoplasms, pubmed-meshheading:11751504-Prognosis, pubmed-meshheading:11751504-RNA, Messenger, pubmed-meshheading:11751504-Stromal Cells, pubmed-meshheading:11751504-Survival Rate, pubmed-meshheading:11751504-Time Factors, pubmed-meshheading:11751504-Transcription, Genetic
pubmed:year
2001
pubmed:articleTitle
Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma.
pubmed:affiliation
Department of Pathology, Sheba Medical Center, Tel-Hashomer 52621, Israel.
pubmed:publicationType
Journal Article